Zhejiang Hisoar Pharmaceutical 483, Aug 2015

Zhejiang Hisoar Pharmaceutical 483, Aug 2015

Peter Baker FDA$119.00

FDA investigators audited the Zhejiang Hisoar Pharmaceutical facility in Taizhou City, China and issued inspectional observations (via FDA 483) on 13 Aug 2015.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 13 Aug 2015
  • Location: Taizhou City, China